322 related articles for article (PubMed ID: 7887131)
1. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
[TBL] [Abstract][Full Text] [Related]
3. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
[TBL] [Abstract][Full Text] [Related]
4. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis.
Fernández-Mestre MT; Vargas V; Montagnani S; Cotúa M; Ogando V; Layrisse Z
Hum Immunol; 2004 Jan; 65(1):54-9. PubMed ID: 14700596
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
[TBL] [Abstract][Full Text] [Related]
6. HLA, anti-DNA, and complement in myasthenia gravis.
Christiansen FT; Houliston JB; Dawkins RL
Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune human T lymphocytes specific for acetylcholine receptor.
Hohlfeld R; Toyka KV; Heininger K; Grosse-Wilde H; Kalies I
Nature; 1984 Jul 19-25; 310(5974):244-6. PubMed ID: 6611507
[TBL] [Abstract][Full Text] [Related]
8. Gm allotypes in myasthenia gravis.
Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
[TBL] [Abstract][Full Text] [Related]
9. Correlation of thymic pathology with HLA in myasthenia gravis.
Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
[TBL] [Abstract][Full Text] [Related]
10. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
Humbert P; Dupond JL; Mallet H; Leconte des Floris R
Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
[No Abstract] [Full Text] [Related]
11. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
[TBL] [Abstract][Full Text] [Related]
12. Gm allotypes in Swedish myasthenia gravis patients.
Smith CI; Grubb R; Hammarström L; Matell G
J Immunogenet; 1983 Feb; 10(1):1-9. PubMed ID: 6601678
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis and HLA antigens in American blacks and other races.
Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
[TBL] [Abstract][Full Text] [Related]
14. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
16. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers.
Pascuzzi RM; Sermas A; Phillips LH; Johns TR
Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.
Demaine A; Willcox N; Janer M; Welsh K; Newsom-Davis J
J Neurol; 1992 Jan; 239(1):53-6. PubMed ID: 1541972
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis.
Manabe K; Donaldson PT; Underhill JA; Doherty DG; Mieli-Vergani G; McFarlane IG; Eddleston AL; Williams R
Hepatology; 1993 Dec; 18(6):1334-7. PubMed ID: 8244257
[TBL] [Abstract][Full Text] [Related]
19. Refractory myasthenia gravis: Characteristics of a portuguese cohort.
Santos E; Bettencourt A; Duarte S; Gabriel D; Oliveira V; da Silva AM; Costa PP; Lopes C; Gonçalves G; da Silva BM; Leite MI
Muscle Nerve; 2019 Aug; 60(2):188-191. PubMed ID: 31050006
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing and human leukocyte antigen analysis in familial myasthenia gravis with thymoma: Case report and literature review.
Nakamura Y; Sato H; Miyano Y; Murakami R; Motoki M; Shigekiyo T; Sugino M; Arawaka S
Clin Neurol Neurosurg; 2021 Sep; 208():106864. PubMed ID: 34388596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
